These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endothelial progenitor cells in cell-based therapy for cardiovascular disease. Rodriguez-Losada N, Garcia-Pinilla JM, Jimenez-Navarro MF, Gonzalez FJ. Cell Mol Biol (Noisy-le-grand); 2008 Oct 26; 54(1):11-23. PubMed ID: 18954547 [Abstract] [Full Text] [Related]
5. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Kawamoto A, Asahara T. Catheter Cardiovasc Interv; 2007 Oct 01; 70(4):477-84. PubMed ID: 17894361 [Abstract] [Full Text] [Related]
6. Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy. Xu S, Zhu J, Yu L, Fu G. J Cardiovasc Pharmacol; 2012 Apr 01; 59(4):387-96. PubMed ID: 22157259 [Abstract] [Full Text] [Related]
7. Endothelial progenitor cells in cardiovascular disorders. Shantsila E, Watson T, Lip GY. J Am Coll Cardiol; 2007 Feb 20; 49(7):741-52. PubMed ID: 17306702 [Abstract] [Full Text] [Related]
10. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Foubert P, Matrone G, Souttou B, Leré-Déan C, Barateau V, Plouët J, Le Ricousse-Roussanne S, Lévy BI, Silvestre JS, Tobelem G. Circ Res; 2008 Sep 26; 103(7):751-60. PubMed ID: 18723447 [Abstract] [Full Text] [Related]
11. Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting. Scheubel RJ, Holtz J, Friedrich I, Borgermann J, Kahrstedt S, Navarrete Santos A, Silber RE, Simm A. Int J Cardiol; 2010 Mar 04; 139(2):134-41. PubMed ID: 19008002 [Abstract] [Full Text] [Related]
12. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Marsboom G, Janssens S. Expert Rev Cardiovasc Ther; 2008 Jun 04; 6(5):687-701. PubMed ID: 18510485 [Abstract] [Full Text] [Related]
14. Potential use of endothelial progenitor cells for regeneration of the vasculature. Yamahara K, Itoh H. Ther Adv Cardiovasc Dis; 2009 Feb 04; 3(1):17-27. PubMed ID: 19144668 [Abstract] [Full Text] [Related]
15. Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies. Khoo CP, Valorani MG, Brittan M, Alison MR, Warnes G, Johansson U, Hawa M, Pozzilli P. Diabetes Metab Res Rev; 2009 Jan 04; 25(1):89-93. PubMed ID: 19065604 [Abstract] [Full Text] [Related]
16. In vivo perfusion of human skin substitutes with microvessels formed by adult circulating endothelial progenitor cells. Kung EF, Wang F, Schechner JS. Dermatol Surg; 2008 Feb 04; 34(2):137-46. PubMed ID: 18190540 [Abstract] [Full Text] [Related]
17. Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases. Brixius K, Funcke F, Graf C, Bloch W. Eur J Cardiovasc Prev Rehabil; 2006 Oct 04; 13(5):705-10. PubMed ID: 17001208 [Abstract] [Full Text] [Related]
18. [Application of endothelial progenitor cells in vascular tissue engineering]. Zhao Y, Xu Z, Cai S. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr 04; 25(2):476-8. PubMed ID: 18610646 [Abstract] [Full Text] [Related]
19. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. Sieveking DP, Buckle A, Celermajer DS, Ng MK. J Am Coll Cardiol; 2008 Feb 12; 51(6):660-8. PubMed ID: 18261686 [Abstract] [Full Text] [Related]
20. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Song MB, Yu XJ, Zhu GX, Chen JF, Zhao G, Huang L. Vascul Pharmacol; 2009 Feb 12; 51(2-3):205-13. PubMed ID: 19577663 [Abstract] [Full Text] [Related] Page: [Next] [New Search]